{"transactions":[{"id":756115,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-02T20:30:17.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":42671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":42671,"derivative":{"exercise_price":5.97,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":42671},"source":{"system":"sec-edgar","filing":"0001891712-26-000002","document":"form4-06022026_040612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000189171226000002/form4-06022026_040612.xml","form_type":"4"}},{"id":756114,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:30:17.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":21335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs will vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":127178,"source":{"system":"sec-edgar","filing":"0001891712-26-000002","document":"form4-06022026_040612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000189171226000002/form4-06022026_040612.xml","form_type":"4"}},{"id":1123807,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-04T20:15:15.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":113246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":113246,"derivative":{"exercise_price":2.785,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":113246},"source":{"system":"sec-edgar","filing":"0001415889-25-015572","document":"form4-06042025_040604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000141588925015572/form4-06042025_040604.xml","form_type":"4"}},{"id":1123806,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:15:15.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":56623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs will vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":105843,"source":{"system":"sec-edgar","filing":"0001415889-25-015572","document":"form4-06042025_040604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000141588925015572/form4-06042025_040604.xml","form_type":"4"}},{"id":1497241,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:18:23.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":98440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":98440,"derivative":{"exercise_price":3.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":98440},"source":{"system":"sec-edgar","filing":"0001415889-24-015040","document":"form4-05312024_040508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000141588924015040/form4-05312024_040508.xml","form_type":"4"}},{"id":1497240,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T20:18:23.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":49220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs will vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":49220,"source":{"system":"sec-edgar","filing":"0001415889-24-015040","document":"form4-05312024_040508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000141588924015040/form4-05312024_040508.xml","form_type":"4"}},{"id":1750751,"issuer":{"id":4549,"kind":"organization","name":"Taysha Gene Therapies, Inc."},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-03T20:41:56.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":43800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in 36 equal monthly installments commencing on December 1, 2023 such that the shares will be fully vested on November 1, 2026, subject to the Reporting Person's continued service as a director through the applicable vesting date."}],"balance_after":43800,"derivative":{"exercise_price":2.385,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":43800},"source":{"system":"sec-edgar","filing":"0001209191-23-054339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806310/000120919123054339/doc4.xml","form_type":"4"}},{"id":2433854,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-18T17:15:22.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer."}],"balance_after":125000,"derivative":{"underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-003532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000120919122003532/doc4.xml","form_type":"4"}},{"id":2433853,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-18T17:15:22.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":46800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest 100% on April 30, 2022 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest 100% on April 30, 2022 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer."}],"balance_after":46800,"derivative":{"underlying":"Common Stock","underlying_shares":46800},"source":{"system":"sec-edgar","filing":"0001209191-22-003532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000120919122003532/doc4.xml","form_type":"4"}},{"id":2469992,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-12-16T17:18:49.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":24350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest 100% on December 15, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest 100% on December 15, 2023."}],"balance_after":24350,"derivative":{"underlying":"Common Stock","underlying_shares":24350},"source":{"system":"sec-edgar","filing":"0001209191-21-070022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000120919121070022/doc4.xml","form_type":"4"}},{"id":2469991,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":42620,"kind":"person","name":"Long Alison S","position":1,"cik":"0001891712","reported_name":"Long Alison S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-16T17:18:49.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest on December 15, 2022, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":300000,"derivative":{"exercise_price":3.08,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-21-070022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000120919121070022/doc4.xml","form_type":"4"}}]}